These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17325561)

  • 21. Accidentally ASCENDing into comparative effective research for inflammatory bowel disease.
    Siegel CA
    Gastroenterology; 2009 Dec; 137(6):1880-2. PubMed ID: 19879213
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experience with Imposit in the treatment of inflammatory involvements in the oral and pharyngeal area].
    Heim G
    Ther Ggw; 1975 Mar; 114(3):411-2, 415-6, 418 PASSIM. PubMed ID: 47655
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
    Eliakim R; Tulassay Z; Kupcinskas L; Adamonis K; Pokrotnieks J; Bar-Meir S; Lavy A; Mueller R; Greinwald R; Chermesh I; Gross V;
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1237-49. PubMed ID: 17944738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of distal ulcerative colitis: frequently asked questions analysis.
    James SL; Irving PM; Gearry RB; Gibson PR
    Intern Med J; 2008 Feb; 38(2):114-9. PubMed ID: 18290827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mesalamine in the treatment of Crohn disease?].
    Nielsen OH; Thomsen OO
    Ugeskr Laeger; 2005 Apr; 167(15):1656-7. PubMed ID: 15892345
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of cell proliferation and invasion in a human colon cancer cell line by 5-aminosalicylic acid.
    Kim YH; Kim MH; Kim BJ; Kim JJ; Chang DK; Son HJ; Rhee PL; Rhee JC
    Dig Liver Dis; 2009 May; 41(5):328-37. PubMed ID: 18976971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates.
    Safdi AV; Cohen RD
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1179-86. PubMed ID: 17944732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Local therapy in the oral and pharyngeal cavitities].
    Spatz E
    Med Monatsschr; 1974 Mar; 28(3):129-31. PubMed ID: 4138114
    [No Abstract]   [Full Text] [Related]  

  • 29. A combination of rectal beclomethasone diproprionate and mesalazine in ulcerative proctitis.
    Guslandi M; Giollo P; Testoni PA
    Scand J Gastroenterol; 2008; 43(5):639-40. PubMed ID: 18415762
    [No Abstract]   [Full Text] [Related]  

  • 30. [Crohn's disease surgery: problems of postoperative recurrence].
    Fornaro R; Frascio M; Stabilini C; Sticchi C; Barberis A; Denegri A; Ricci B; Azzinnaro A; Lazzara F; Gianetta E
    Chir Ital; 2008; 60(6):761-81. PubMed ID: 19256268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment.
    Bresci G; Parisi G; Capria A
    Colorectal Dis; 2008 Oct; 10(8):814-7. PubMed ID: 18834420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Patients prefer foam].
    MMW Fortschr Med; 2007 May; 149(21):48. PubMed ID: 17668735
    [No Abstract]   [Full Text] [Related]  

  • 33. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinsalicylate gel induced oral lesion: report of case.
    Sapir S; Bimstein E
    J Clin Pediatr Dent; 2000; 24(2):103-6. PubMed ID: 11314315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoprevention of colorectal cancer in inflammatory bowel disease.
    Butterworth JR
    Dig Liver Dis; 2009 May; 41(5):338-9. PubMed ID: 19268635
    [No Abstract]   [Full Text] [Related]  

  • 36. The management of oral mucous membrane pemphigoid with dapsone and topical corticosteroid.
    Arash A; Shirin L
    J Oral Pathol Med; 2008 Jul; 37(6):341-4. PubMed ID: 18331284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide for the treatment of oral aphthous ulcers in Crohn's disease.
    Weinstein TA; Sciubba JJ; Levine J
    J Pediatr Gastroenterol Nutr; 1999 Feb; 28(2):214-6. PubMed ID: 9932860
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of topical application of pirfenidone ointment on thermoplasty-induced acute lameness in a double-blind and acute and chronic lameness of musculoskeletal origin in an open multi-centered field trial in horses.
    Giri SN; Margolin SB
    Res Commun Mol Pathol Pharmacol; 2005; 117-118():47-63. PubMed ID: 18426078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Stomatological manifestations of Crohn's disease].
    Gabioud F; Carrel JP; Samson J
    Rev Prat; 1999 Jun; 49(12):1258-60. PubMed ID: 10488655
    [No Abstract]   [Full Text] [Related]  

  • 40. Severe recurrent oral ulceration secondary to erosive lichen planus.
    Nadeem A; Khan S; Murtaza B; Butt MR; Satti AA
    J Coll Physicians Surg Pak; 2008 Feb; 18(2):107-9. PubMed ID: 18454898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.